Tumor-infiltrating lymphocyte (TIL) immunotherapy

tumor-infiltrating lymphocytes

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tumor-infiltrating lymphocyte (TIL) immunotherapy, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer [Phase 2]